Insulin degrading enzyme Blocking Peptide for STJ501383 peptide (STJ504242)
SPECIFICATIONS
ImmunogenSynthetic peptide taken within amino acid region 100-150 on human Insulin-degrading enzyme protein.
General Information
| Short Description | Insulin degrading enzyme Blocking Peptide for STJ501383 is synthetically produced from the 100-150 sequence and is suitable for use in western blot applications. |
| Applications | Immunodepletion/Immunocompetition |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Formulation | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction | Store at-20ยฐC for long term storage. Avoid freeze-thaw cycles. |
Target Information
| Immunogen | Synthetic peptide taken within amino acid region 100-150 on human Insulin-degrading enzyme protein. |
| Immunogen Region | 100-150 |
| Specificity | This blocking peptide is recommended for use in combination with Insulin degrading enzyme antibody, STJ501383 |
Additional Info
| Background | Plays a role in the cellular breakdown of insulin, IAPP, glucagon, bradykinin, kallidin and other peptides, and thereby plays a role in intercellular peptide signaling. Degrades amyloid formed by APP and IAPP. May play a role in the degradation and clearance of naturally secreted amyloid beta-protein by neurons and microglia. |
Information sourced from Uniprot.org